Canton Fitzgerald

Canton Fitzgerald's Elemer Piros initiated Dimension Therapeutics Inc (NASDAQ: DMTX) at Buy with a $32.00 price objective. "Dimension has assembled a suite of potentially best-in-class liver-targeted gene therapies" with a $275-million-dollar licensing agreement with Bayer...